Lexpos News

The Lateral flow device tests supply service for patients potentially eligible for COVID-19 treatments (LFD service) will continue to be commissioned as an Advanced service through 2026/27. NHS England has agreed the fee for provision of the service will increase to £4.19 + VAT from 1st April 2026, following a request from Community Pharmacy England [...]

The post C-19 LFD service: commissioning continues through 2026/27 appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Chlordiazepoxide 5mg and 10mg capsules. MSN/2026/021 Tier 2 – Medium impact Date of issue: 30 March 2026 Chlordiazepoxide 5mg and 10mg capsules (Viatris) are out of stock until mid-July 2026. Chlordiazepoxide 10mg capsules (Kent Pharma) have been discontinued. Chlordiazepoxide 5mg capsules [...]

The post Medicine Supply Notification: Chlordiazepoxide 5mg and 10mg capsules appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Cefixime (Suprax®) 200mg tablets. MSN/2026/020 Tier 2 – medium impact Date of issue: 30 March 2026 Cefixime (Suprax®) 200mg tablets are in limited supply until mid-October 2026. Alternative broad-spectrum antibiotics remain available. Unlicensed supplies may be sourced, lead times vary. Unlicensed [...]

The post Medicine Supply Notification: Cefixime (Suprax® ) 200mg tablets appeared first on Community Pharmacy England.

23 new products (including those with multiple flavours) have been added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 April 2026. Community Pharmacy England, on behalf of pharmacy owners, applied to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA) for these products to [...]

The post 23 products added to the Discount Not Deducted (DND) list from April 2026 appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Recall: Rabies, Human normal Immunoglobulin 500IU solution for Injection (Bio Products Laboratory Limited) Drug alert number: EL(26)A/18 Date issued: 30 March 2026 Bio Products Laboratory Limited is recalling one batch of Human Rabies Immunoglobulin following a stability failure for this batch. The batch has shown a reduction in potency of the [...]

The post MHRA Class 2 Medicines Recall: Rabies, Human normal Immunoglobulin 500IU solution for Injection (Bio Products Laboratory Limited) appeared first on Community Pharmacy England.